M. Sokolosky

GSK-3 as potential target for therapeutic intervention in cancer

Stephen L. Abrams, Fred E. Bertrand, F. E. Bertrand, 2014, Oncotarget.

Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors

Stephen L. Abrams, D. Terrian, J. McCubrey, 2008, Oncogene.

Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted Therapy

Stephen L. Abrams, J. McCubrey, F. Nicoletti, 2011, Oncotarget.

Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells

J. McCubrey, W. Chappell, L. Steelman, 2014, Cell cycle.

Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy.

Stephen L. Abrams, D. Terrian, J. McCubrey, 2008, Advances in enzyme regulation.

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

Stephen L. Abrams, Alberto M. Martelli, Saverio Candido, 2014, Oncotarget.

Fusogenic-Oligoarginine Peptide-Mediated Delivery of siRNAs Targeting the CIP2A Oncogene into Oral Cancer Cells

A. Jakymiw, M. Sokolosky, C. Attaway, 2013, PloS one.

Homeostatic Imbalance and Colon Cancer: The Dynamic Epigenetic Interplay of Inflammation, Environmental Toxins, and Chemopreventive Plant Compounds

M. Wargovich, M. Sokolosky, Melissa L. Sokolosky, 2012, Front. Oncol..